LD-2 disclosure · 4th Quarter - Report
EQRX INTERNATIONAL, INC.
Client
- Name
- EQRX INTERNATIONAL, INC.
- Description
- Pharmaceutical manufacturer
- Location
- Massachusetts · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues and policies impacting innovation in drug development S. 908 (Medicare Drug Price Negotiation Act), all provisions S. 909 (Prescription Drug Price Relief Act of 2021), all provisions S. 1427 (Increasing Access to Biosimilars Act of 2021), regarding Centers for Medicare and Medicaid Services Innovation Center shared savings demonstration projects H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act), all provisions Draft legislation (21st Century Cures Act 2.0), regarding innovation in drug development S. 1898 (Affordable Medications Act), all provisions Health Savings Accounts generally H.R. 5376 (Build Back Better Act), Title XIII, Subtitle J, regarding drug pricing H.R. 5801 (HELP Copays Act), all provisions
LobbyistsDAN RENBERG · BYRON DORGAN · OLIVER SPURGEON III